drugset / Trial / NCT04268953

Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

NCT04268953 ↗

Phase 1 Completed 12 enrolled Cerecin
SequentialOpen-labelBasic science

Summary

This is a Phase I, single center, open label, multiple dose, pharmacokinetic (PK) study recruiting healthy older subjects.

Timeline

Start
2020-02-27
Primary completion
2020-03-26
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tricaprilin Other / unclassified — —

Indications